Carduso Capital

What is Carduso Capital?

Carduso Capital is a venture capital firm based in Groningen, Netherlands, with a focus on investing in technology companies operating in life sciences, healthy ageing, energy, and sustainable society.

They target sectors such as Healthcare (& Wellness), Life Science, Nanotechnology, and Oil & Gas (& Mining). Their investment thesis is grounded in supporting innovative ventures where science transforms into viable business propositions, emphasizing the translation of scientific advancements into commercial opportunities. With an eye for groundbreaking developments, Carduso Capital provides not only financial investments but also strategic support to nurture and grow their portfolio companies.

This approach is exemplified by their involvement in companies that have achieved significant milestones or awards, such as VRelax, a portfolio company that won the Prix Galien MedTech Innovation Award in 2021. Carduso's investments also include Notoxins, which develops treatments for excessive sweating, and QDI-Systems, which is innovating in quantum dot X-ray technology.

Additionally, they have invested in Ivy Medical, demonstrating their commitment to advancing patients' mobility and recovery through wearable medical devices.

The firm places great importance on partnership and collaboration as key components of their strategy, working closely with their investors, partners, and portfolio companies to achieve mutually beneficial outcomes and long-term growth. Their mission is to foster a vibrant ecosystem where scientific research can thrive and lead to substantial improvements in various domains, ultimately contributing to a healthier and more sustainable society.

What they say:

We invest in technology companies.